According to a recent study on gliomas, five genes related to m5C methyltransferase were identified to construct a risk signature (5MM) and were used to predict glioma prognosis (Wang et al., 2020), including NOP2, NSUN4, NSUN5, NSUN6 and NSUN7. This evidence concerns the gene NSUN6 and central nervous system cancer.